medigraphic.com
Revista Médica Sinergia

2020, Number 08

<< Back Next >>

Revista Médica Sinergia 2020; 5 (08)

Vitiligo overview

Fernández PD, Valdés EJ, Valverde MP

Language: Spanish
References: 22
Page: 1-13
PDF size: 198.82 Kb.


ABSTRACT

Vitiligo is an autoimmune acquired hypomelanosis, which has an important genetic component and is usually associated with other environmental triggers. It`s typical clinic manifestation of hypochromic or achromic macules with progressive behavior make it a relatively easy diagnosis. Vitiligo usually affects visible areas of the body having an important emotional impact for the patients, so psychological therapy is essential for the management of the disease. The treatment is oriented to stop the progression of the disease, help repigmentation and avoid relapses through the use of topical steroids, systemic steroids and phototherapy, with the final goal of improving quality of life.


REFERENCES

  1. Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, Pasquariello B, Magliulo G. Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews. 2016 04;15(4):335- 343. https://doi.org/10.1016/j.autrev.2015.12.006

  2. Xie, H. et al. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci. 2015; https://doi.org/10.1016/j.jdermsci.2015.09.003

  3. Speeckaert, R. et al. Vitiligo: An Update on Pathophysiology and Treatment Options. Am J Clin Dermatol. 2017; 18: 733-744. https://doi.org/10.1007/s40257-017-0298-5

  4. Rashighi, M. et al. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017; 35 (2): 257-265 https://doi.org/10.1016/j.det.2016.11.014

  5. Mole, M. y Coringrato, M. Actualización sobre el vitíligo. Dermatología Argentina. 2019; 25 (2): 50-57. Disponible: http://www.dermatolarg.org.ar/index.php/dermatolarg/article/viewArticle/1874

  6. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview. Journal of the American Academy of Dermatology. 2011 09;65(3):473-491. https://doi.org/10.1016/j.jaad.2010.11.061

  7. Rodrigues, M. et al. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017; 77:1-13. http://dx.doi.org/10.1016/j.jaad.2016.10.048

  8. Picardo M, Dell'Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nature Reviews Disease Primers. 2015 06 04;1(1). https://doi.org/10.1038/nrdp.2015.11

  9. Boniface, K. et al. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clinic Rev Allerg Immunol. (2018); 54:52-67. https://doi.org/10.1007/s12016-017-8622-7

  10. Goh B, Pandya AG. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo. Dermatologic Clinics. 2017 04;35(2):135-144. https://doi.org/10.1016/j.det.2016.11.004

  11. Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review. International Journal of Dermatology. 2018 05 28;57(10):1157-1164. https://doi.org/10.1111/ijd.14055

  12. Blanca Lucina Campos-Cabrera, Juan Carlos Juárez-Echenique, Marimar Saez-de Ocariz, Luz OrozcoCovarrubias. Asociación entre vitíligo y alteraciones oftalmológicas. Dermatol Rev Mex. 2019; 63 (3): 268-277. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd-2019/rmd193d.pdf

  13. Elbuluk N, Ezzedine K. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients. Dermatologic Clinics. 2017 04;35(2):117-128. https://doi.org/10.1016/j.det.2016.11.002

  14. Passeron T. Medical and Maintenance Treatments for Vitiligo. Dermatologic Clinics. 2017 04;35(2):163- 170. https://doi.org/10.1016/j.det.2016.11.007

  15. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. The Lancet. 2015 07;386(9988):74- 84. https://doi.org/10.1016/s0140-6736(14)60763-7

  16. Hönigsmann, H. y Schwarz, H. Tratamiento con luz ultravioleta, Modalidades de tratamiento físico. 2019; 2325-2341

  17. Zubair R, Hamzavi IH. Phototherapy for Vitiligo. Dermatologic Clinics. 2020 01;38(1):55- 62. https://doi.org/10.1016/j.det.2019.08.005

  18. Esmat S, Hegazy RA, Shalaby S, Chu-Sung Hu S, Lan CE. Phototherapy and Combination Therapies for Vitiligo. Dermatologic Clinics. 2017 04;35(2):171-192. https://doi.org/10.1016/j.det.2016.11.008

  19. Mohammad TF, Hamzavi IH. Surgical Therapies for Vitiligo. Dermatologic Clinics. 2017 04;35(2):193- 203. https://doi.org/10.1016/j.det.2016.11.009

  20. Grimes PE, Nashawati R. Depigmentation Therapies for Vitiligo. Dermatologic Clinics. 2017 04;35(2):219- 227. https://doi.org/10.1016/j.det.2016.11.010

  21. Cupertino F, Niemeyer-Corbellini JP, Ramos-e-Silva M. Psychosomatic aspects of vitiligo. Clinics in Dermatology. 2017 05;35(3):292-297. https://doi.org/10.1016/j.clindermatol.2017.01.001

  22. Díaz, Y. et al. Trastorno depresivo recurrente en paciente con vitíligo. Mediciego. 2019; 25(1): 60-64




2020     |     www.medigraphic.com